| SC 13G/A | 2020-02-12 | ADAGE CAPITAL PARTNERS GP, L.L.C. | Aldeyra Therapeutics, Inc. | 1,000,000 | 3.6% | EDGAR |
| SC 13G/A | 2020-02-07 | FMR LLC | Aldeyra Therapeutics, Inc. | 1,341,633 | 4.8% | EDGAR |
| SC 13G | 2020-02-07 | BlackRock Inc. | Aldeyra Therapeutics, Inc. | 1,584,625 | 5.7% | EDGAR |
| SC 13G/A | 2020-01-10 | Domain Partners VI, L.P. | Aldeyra Therapeutics, Inc. | 1,877,091 | 6.7% | EDGAR |
| SC 13G | 2019-09-27 | ADAGE CAPITAL PARTNERS GP, L.L.C. | Aldeyra Therapeutics, Inc. | 1,418,822 | 5.1% | EDGAR |
| SC 13G/A | 2019-02-14 | 683 Capital Management, LLC | Aldeyra Therapeutics, Inc. | 1,393,700 | 5.3% | EDGAR |
| SC 13G/A | 2019-02-14 | PERCEPTIVE ADVISORS LLC | Aldeyra Therapeutics, Inc. | 3,085,458 | 11.8% | EDGAR |
| SC 13G/A | 2019-02-13 | FMR LLC | Aldeyra Therapeutics, Inc. | 2,564,333 | 9.8% | EDGAR |
| SC 13G/A | 2019-02-13 | SPHERA FUNDS MANAGEMENT LTD. | Aldeyra Therapeutics, Inc. | 1 | 4.7% | EDGAR |
| SC 13G/A | 2019-01-22 | JOHNSON & JOHNSON | Aldeyra Therapeutics, Inc. | 1,050,292 | 4.0% | EDGAR |
| SC 13G/A | 2018-02-14 | PERCEPTIVE ADVISORS LLC | Aldeyra Therapeutics, Inc. | 3,085,458 | 16.1% | EDGAR |
| SC 13G/A | 2018-02-13 | SPHERA FUNDS MANAGEMENT LTD. | Aldeyra Therapeutics, Inc. | 1,159,131 | 6.0% | EDGAR |
| SC 13G | 2018-01-22 | 683 Capital Management, LLC | Aldeyra Therapeutics, Inc. | 1,000,000 | 5.2% | EDGAR |
| SC 13G/A | 2017-10-10 | FMR LLC | Aldeyra Therapeutics, Inc. | 1,611,311 | 8.7% | EDGAR |
| SC 13G/A | 2017-05-09 | AWM Investment Company, Inc. | Aldeyra Therapeutics, Inc. | 460,852 | 3.0% | EDGAR |
| SC 13G | 2017-02-21 | SPHERA FUNDS MANAGEMENT LTD. | Aldeyra Therapeutics, Inc. | 783,500 | 6.2% | EDGAR |
| SC 13G/A | 2017-02-14 | FMR LLC | Aldeyra Therapeutics, Inc. | 1,797,811 | 14.3% | EDGAR |
| SC 13G/A | 2017-02-14 | PERCEPTIVE ADVISORS LLC | Aldeyra Therapeutics, Inc. | 1,940,458 | 15.4% | EDGAR |
| SC 13G/A | 2017-02-14 | Flynn James E | Aldeyra Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G | 2017-02-10 | MARXE AUSTIN W & GREENHOUSE DAVID M | Aldeyra Therapeutics, Inc. | 912,610 | 7.3% | EDGAR |